- · 208 Swiss SME transactions closed in 2025, a 16% year-on-year increase, with financial investors involved in 56% of all deals.
- · Inbound foreign acquisitions reached 104, the highest count recorded since Deloitte began tracking the market in 2013.
- · Approximately 168,000 Swiss SMEs face an ownership transfer by 2030, and 42% of MEM-sector owners are actively ruling out a family handover.
- · Valuation multiples vary widely by sector, from 5–8× EBITDA for standard transactions to 10–14× for businesses with recurring revenue and low customer concentration.
Swiss SME ownership has long been shaped by a particular cultural grammar: the founder passes the enterprise to a son, a daughter, or a trusted long-term manager, and the business carries on under a familiar name. That grammar has not disappeared, but the 2025 transaction data suggests it is being revised at a pace that warrants close attention.
According to Deloitte Switzerland's annual M&A Activity of Swiss SME report, 208 Swiss SME transactions closed in 2025, representing a 16% increase on the prior year. More telling than the headline volume is the composition of buyers: financial investors, comprising private equity firms and family offices, were involved in 56% of all deals, up 45% year-on-year. That figure is not a rounding error. It reflects a sustained, structurally motivated reorientation of capital toward a market that was, not long ago, considered too fragmented and too relationship-dependent for institutional appetite.
Inbound acquisitions by foreign buyers reached 104 in 2025, the highest count recorded since Deloitte began tracking this market in 2013. The Swiss SME, long regarded as a domestic asset, is now a recognised target class on the international M&A map.
The demand side of this equation is well understood in professional circles, but the supply side is where the real structural story lives. The CFB-HSG and UBS Unternehmensnachfolge-Kurzstudie 2026 estimates that approximately 168,000 Swiss SMEs face an ownership transfer by 2030. That is not a forecast built on modest assumptions. It reflects the demographic reality of a generation of founders who built businesses through the 1980s and 1990s and are now at or past conventional retirement age.
What makes the current wave particularly consequential for institutional buyers is the growing reluctance of the next generation to step in. A Swissmechanic survey conducted in December 2025 found that 42% of owners in the MEM sector, covering mechanical engineering, electrical engineering, and metalworking, are actively ruling out a family handover. The reasons are varied: complexity of international supply chains, capital intensity of modernisation, and, in some cases, simply the absence of a willing heir.
The result is a structural misalignment between the supply of businesses coming to market and the pool of traditional succession counterparties. Private equity and family offices are filling that gap, and the 2025 data confirms they are doing so at scale.
The arbitrage between family-succession pricing and institutional-buyer pricing is the defining dynamic for any owner weighing timing and counterparty choice in 2026.
For owners, advisors, and institutional buyers alike, the most operationally relevant dimension of this shift is valuation. And the spread across sectors is wide enough to matter considerably in any given transaction.
ValIndex data for 2026, drawing on Dealsuite DACH, PwC, EY, and KPMG M&A datasets, places Swiss SME deal multiples across the following ranges. SaaS and B2B software businesses are transacting at 7.5 to 12.5 times EV/EBITDA. MedTech and medical device companies sit in the 8.0 to 14.0 times range. Precision engineering, a category with deep roots in Swiss industrial heritage, occupies a somewhat narrower corridor of 6.0 to 8.0 times.
The European SME mid-market median, as tracked by the Argos Index from Epsilon Research, was anchored at 8.3 times EBITDA in Q4 2025. Standard Swiss SME transactions, taken in the aggregate, closed in the 5 to 8 times range. Businesses with recurring revenue profiles and low customer concentration achieved considerably more, in the 10 to 14 times band.
The gap between a business that closes at 5.5 times and one that closes at 11.5 times is not primarily a function of sector luck. It is a function of revenue quality, customer structure, management depth, and the degree to which the business can be understood and underwritten by a buyer who was not introduced to it over dinner fifteen years ago. Institutional buyers are, by training, oriented toward the latter category. The premium they are willing to pay for clarity and transferability is precisely what creates the valuation arbitrage currently visible in the Swiss SME market.
It is worth noting, as context for the broader Swiss deal environment, that adjacent sectors are demonstrating the same pattern of international capital attraction. The Swiss Biotech Report 2026 recorded sector revenue of CHF 7.5 billion in 2025, up from CHF 7.2 billion the prior year, with private company investment rising 38% to CHF 1.15 billion. While biotech operates on a different transaction logic than the typical SME succession deal, the underlying signal is consistent: Switzerland remains a preferred destination for cross-border institutional capital, and that confidence extends from listed biotechs down to unlisted, owner-managed businesses in precision engineering and B2B software.
For an SME owner who has spent three decades building a business, the choice of counterparty is rarely reducible to a multiple. Culture, continuity of employment, and the preservation of the enterprise as a going concern all enter the calculus. But 2025 data suggests that institutional buyers have become adept at structuring transactions that address these concerns, whether through earnout arrangements, management retention packages, or partial sale structures that allow founders to retain a meaningful stake during a transition period.
Family offices, in particular, occupy an interesting intermediate position in this market. They offer patient capital horizons closer to those of a family buyer, combined with the analytical rigour and financial capacity of an institutional counterparty. Their rising share of Swiss SME transactions is not incidental. It reflects a deliberate repositioning by sophisticated capital toward a market where supply is growing, competition from strategic buyers remains selective, and the underlying businesses, many of them precision manufacturers, niche software providers, or specialist service firms, carry durable competitive positions.
The structural conditions that produced the 2025 transaction volume show no sign of reversal. The demographic pipeline of owners approaching succession age continues to build. The share of those ruling out intra-family transfer is, if anything, trending upward. And the appetite of financial investors for Swiss SME assets, validated by a record year of inbound acquisitions, is now supported by the infrastructure of cross-border deal sourcing that did not exist a decade ago.
For institutional buyers, the risk in this environment is not scarcity of supply. It is the discipline to distinguish, at scale, between businesses that merit premium multiples and those that are being brought to market precisely because no family buyer was prepared to pay for their complexity. For owners, the risk is the mirror image: entering a process without a clear understanding of which buyer category their business is most likely to attract, and at what valuation, given its specific revenue profile and ownership structure.
The data, as it stands in mid-2026, is a market observation, not a prescription. But the direction of travel is legible. Financial investors are now the modal buyer in Swiss SME transactions. That is a structural fact with practical implications for every owner, advisor, and institutional counterparty active in this market.
All transaction and valuation data referenced in this article is drawn from publicly available research including Deloitte Switzerland, ValIndex, the CFB-HSG and UBS Unternehmensnachfolge-Kurzstudie, Swissmechanic, and the Argos Index by Epsilon Research. This post constitutes market observation only and does not constitute investment advice or any form of transaction recommendation.